1. Home
  2. RCG vs TPST Comparison

RCG vs TPST Comparison

Compare RCG & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RCG

RENN Fund Inc

HOLD

Current Price

$2.74

Market Cap

18.1M

Sector

Finance

ML Signal

HOLD

Logo Tempest Therapeutics Inc.

TPST

Tempest Therapeutics Inc.

HOLD

Current Price

$2.47

Market Cap

15.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCG
TPST
Founded
1994
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
15.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RCG
TPST
Price
$2.74
$2.47
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
5.9K
86.5K
Earning Date
01-01-0001
11-05-2025
Dividend Yield
0.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.52
$2.40
52 Week High
$1.90
$12.48

Technical Indicators

Market Signals
Indicator
RCG
TPST
Relative Strength Index (RSI) 60.80 36.74
Support Level $2.60 $2.43
Resistance Level $2.75 $3.00
Average True Range (ATR) 0.09 0.22
MACD 0.01 0.04
Stochastic Oscillator 70.82 19.20

Price Performance

Historical Comparison
RCG
TPST

About RCG RENN Fund Inc

RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Share on Social Networks: